Literature DB >> 33400675

Mobile App-Based Remote Patient Monitoring in Acute Medical Conditions: Prospective Feasibility Study Exploring Digital Health Solutions on Clinical Workload During the COVID Crisis.

Sachin Shailendra Shah1, Andrew Gvozdanovic1, Matthew Knight2, Julien Gagnon1.   

Abstract

BACKGROUND: Digital remote patient monitoring can add value to virtual wards; this has become more apparent in the context of the COVID-19 pandemic. Health care providers are overwhelmed, resulting in clinical teams spread more thinly. We aimed to assess the impact of introducing an app-based remote patient monitoring system (Huma Therapeutics) on a clinician's workload in the context of a COVID-19-specific virtual ward.
OBJECTIVE: This prospective feasibility study aimed to evaluate the health economic effects (in terms of clinical workload) of a mobile app on a telephone-based virtual ward used in the monitoring of patients with COVID-19 who are clinically ready for discharge from the hospital.
METHODS: A prospective feasibility study was carried out over 1 month where clinician workload was monitored, and full-time equivalents savings were determined. An NHS hospital repurposed a telephone-based respiratory virtual ward for COVID-19. Patients with COVID-19 in the amber zone (according to the National Health Service definition) were monitored for 14 days postdischarge to help identify deteriorating patients earlier. A smartphone-based app was introduced to monitor data points submitted by the patients via communication over telephone calls. We then comparatively evaluated the clinical workload between patients monitored by telephone only (cohort 1) with those monitored via mobile app and telephone (cohort 2).
RESULTS: In all, 56 patients were enrolled in the app-based virtual ward (cohort 2). Digital remote patient monitoring resulted in a reduction in the number of phone calls from a mean total of 9 calls to 4 calls over the monitoring period. There was no change in the mean duration of phone calls (8.5 minutes) and no reports of readmission or mortality. These results equate to a mean saving of 47.60 working hours. Moreover, it translates to 3.30 fewer full-time equivalents (raw phone call data), resulting in 1.1 fewer full-time equivalents required to monitor 100 patients when adjusted for time spent reviewing app data. Individual clinicians spent an average of 10.9 minutes per day reviewing data.
CONCLUSIONS: Smartphone-based remote patient monitoring technologies may offer tangible reductions in clinician workload at a time when service is severely strained. In this small-scale pilot study, we demonstrated the economic and operational impact that digital remote patient monitoring technology can have in improving working efficiency and reducing operational costs. Although this particular RPM solution was deployed for the COVID-19 pandemic, it may set a precedent for wider utilization of digital, remote patient monitoring solutions in other clinical scenarios where increased care delivery efficiency is sought. ©Sachin Shailendra Shah, Andrew Gvozdanovic, Matthew Knight, Julien Gagnon. Originally published in JMIR Formative Research (http://formative.jmir.org), 15.01.2021.

Entities:  

Keywords:  COVID-19; cost-effectiveness; digital health; mHealth; monitoring; remote patient monitoring; service improvement

Year:  2021        PMID: 33400675     DOI: 10.2196/23190

Source DB:  PubMed          Journal:  JMIR Form Res        ISSN: 2561-326X


  9 in total

1.  The Current State of Mobile Apps Owned by Large Pediatric Hospitals in the United States: Systematic Search and Analysis on Google Play and Apple App Stores.

Authors:  Tyler Lieser; Yungui Huang; Emre Sezgin
Journal:  JMIR Pediatr Parent       Date:  2022-10-06

2.  Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study.

Authors:  Mohammad A Dabbah; Angus B Reed; Adam T C Booth; Arrash Yassaee; Aleksa Despotovic; Benjamin Klasmer; Emily Binning; Mert Aral; David Plans; Davide Morelli; Alain B Labrique; Diwakar Mohan
Journal:  Sci Rep       Date:  2021-08-19       Impact factor: 4.379

Review 3.  Enablers and barriers in upscaling telemonitoring across geographic boundaries: a scoping review.

Authors:  Harm Gijsbers; Tim M Feenstra; Nina Eminovic; Debora van Dam; Shaikh Azam Nurmohamed; Tom van de Belt; Marlies P Schijven
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

4.  An Early Warning Mobile Health Screening and Risk Scoring App for Preventing In-Hospital Transmission of COVID-19 by Health Care Workers: Development and Feasibility Study.

Authors:  Ronald Mbiine; Cephas Nakanwagi; Herve Monka Lekuya; Joan Aine; Kawesi Hakim; Lilian Nabunya; Henry Tomusange
Journal:  JMIR Form Res       Date:  2021-12-17

5.  Development of an integrated solution for patients with neurostimulator for chronic pain in times of COVID-19: A mobile application with a support center.

Authors:  Nicolás Cordero Tous; Lucía Santos Martín; Carlos Sánchez Corral; Ana María Román Cutillas; Belén Núñez Alfonsel; Marta Román Moyano; Ángel Horcajadas Almansa
Journal:  Neurocirugia (Astur : Engl Ed)       Date:  2021-12-24

6.  Chinese Version of the mHealth App Usability Questionnaire: Cross-Cultural Adaptation and Validation.

Authors:  Shuqing Zhao; Yingjuan Cao; Heng Cao; Kao Liu; Xiaoyan Lv; Jinxin Zhang; Yuxin Li; Patricia M Davidson
Journal:  Front Psychol       Date:  2022-02-02

7.  Smartphone movement sensors for the remote monitoring of respiratory rates: Technical validation.

Authors:  Sophie Valentine; Adam C Cunningham; Benjamin Klasmer; Mohammad Dabbah; Marko Balabanovic; Mert Aral; Dan Vahdat; David Plans
Journal:  Digit Health       Date:  2022-04-25

8.  Post-acute care management of a patient with COVID-19 using remote cardiorespiratory monitoring.

Authors:  Michael B Polsky; Neema Moraveji
Journal:  Respir Med Case Rep       Date:  2021-06-15

9.  Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19.

Authors:  Sreekar Mantena; Salmaan Keshavjee
Journal:  BMJ Health Care Inform       Date:  2021-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.